Array Genomics

France

Back to Profile

1-3 of 3 for Array Genomics Sort by
Query
Aggregations
Jurisdiction
        United States 2
        World 1
IPC Class
C12Q 1/68 - Measuring or testing processes involving enzymes, nucleic acids or microorganismsCompositions thereforProcesses of preparing such compositions involving nucleic acids 3
C07H 21/02 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical 2
C07H 21/04 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical 2
G01N 33/48 - Biological material, e.g. blood, urineHaemocytometers 2
G01N 33/50 - Chemical analysis of biological material, e.g. blood, urineTesting involving biospecific ligand binding methodsImmunological testing 2
See more
Found results for  patents

1.

Method for the urinary detection of bladder cancer

      
Application Number 14730595
Grant Number 09617603
Status In Force
Filing Date 2015-06-04
First Publication Date 2015-11-12
Grant Date 2017-04-11
Owner Array Genomics (France)
Inventor
  • Cussenot, Olivier
  • Lozach, François
  • Jones, Ian
  • Metters, Neil

Abstract

The invention relates to the diagnosis of bladder cancer and more specifically to the detection in urine samples of bladder carcinomas of the transitional type. The detection method according to the present invention enables, through the utilization of a DNA chip designed for this purpose, to determine the grade of the detected tumors.

IPC Classes  ?

  • C12Q 1/68 - Measuring or testing processes involving enzymes, nucleic acids or microorganismsCompositions thereforProcesses of preparing such compositions involving nucleic acids
  • C07H 21/02 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical
  • C07H 21/04 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
  • C12P 21/04 - Cyclic or bridged peptides or polypeptides, e.g. bacitracin
  • G09B 9/56 - Simulation of sonar
  • G01N 33/48 - Biological material, e.g. blood, urineHaemocytometers
  • G01N 33/50 - Chemical analysis of biological material, e.g. blood, urineTesting involving biospecific ligand binding methodsImmunological testing

2.

Method for the urinary detection of bladder cancer

      
Application Number 13107038
Grant Number 08921070
Status In Force
Filing Date 2011-05-13
First Publication Date 2011-11-10
Grant Date 2014-12-30
Owner Array Genomics (France)
Inventor
  • Cussenot, Olivier
  • Jones, Ian
  • Metters, Neil
  • Lozach, François

Abstract

The invention relates to the diagnosis of bladder cancer and more specifically to the detection in urine samples of bladder carcinomas of the transitional type. The detection method according to the present invention enables, through the utilization of a DNA chip designed for this purpose, to determine the grade of the detected tumors.

IPC Classes  ?

  • C12Q 1/68 - Measuring or testing processes involving enzymes, nucleic acids or microorganismsCompositions thereforProcesses of preparing such compositions involving nucleic acids
  • C07H 21/02 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical
  • C07H 21/04 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
  • C12P 21/06 - Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
  • G09B 9/56 - Simulation of sonar
  • G01N 33/48 - Biological material, e.g. blood, urineHaemocytometers
  • G01N 33/50 - Chemical analysis of biological material, e.g. blood, urineTesting involving biospecific ligand binding methodsImmunological testing

3.

METHOD FOR THE URINARY DETECTION OF BLADDER CANCER.

      
Application Number IB2009054987
Publication Number 2010/055467
Status In Force
Filing Date 2009-11-10
Publication Date 2010-05-20
Owner ARRAY GENOMICS (France)
Inventor
  • Cussenot, Olivier
  • Jones, Ian
  • Metters, Neil
  • Lozach, François

Abstract

The invention relates to the diagnosis of bladder cancer and more specifically to the detection in urine samples of bladder carcinomas of the transitional type. The detection method according to the present invention enables, through the utilization of a DNA chip designed for this purpose, the grade of the detected tumors to be determined.

IPC Classes  ?

  • C12Q 1/68 - Measuring or testing processes involving enzymes, nucleic acids or microorganismsCompositions thereforProcesses of preparing such compositions involving nucleic acids